Interaction between PD-1 and the TME, as well as ensuring cancer immunotherapy therapeutics. The paper mentions the inhibition of PD-1, PD-L1, and PD-L2, the construction of CAR-T, and tumor vaccines as popular therapeutic approaches. The gene discussed is CD274; the disease is cancer.